PART 2: How the wellness industry misled you about cholesterol скачать в хорошем качестве

PART 2: How the wellness industry misled you about cholesterol

In Part 1, I shared how my own bloodwork forced me to question everything I thought I knew about cholesterol. In this episode, we go deeper — into the markers that actually predict cardiovascular risk and why so many women are being reassured by tests that don’t tell the full story. Because a “normal” cholesterol panel doesn’t mean your risk is low. It often just means the most important markers were never measured. I walk you through the two advanced markers that can completely change how we understand heart disease risk — especially when genetics are involved — and why these tests are essential if you want a clear, accurate picture of your cardiovascular health. We also have an honest conversation about cholesterol-lowering medications: what they do, when they make sense, and why modern medicine can be protective when used thoughtfully and strategically. This isn’t about fear. It’s about clarity. It’s about having the full picture so you can make informed decisions about your health and your future. In this episode of The Perimenopause Solution Podcast, you’ll learn: • Why a standard cholesterol panel often misses true cardiovascular risk • What Lipoprotein(a) is and why genetics play a major role • Why ApoB is one of the strongest predictors of heart disease • How advanced markers change risk assessment — even when traditional labs look “normal” • The truth about cholesterol-lowering medications and how they work in the body • When lifestyle is enough — and when additional support may be protective • How to advocate for the testing and information you deserve If you’ve ever been told your cholesterol looks “fine,” this episode will help you understand what may still be missing — and why that matters.